PetIQ, Inc. PETQ
Set alert
At close · Oct 24
52-week range unavailable
- Open
- 30.99
- Prev close
- 30.98
- Mkt cap
- 919.17M
- Vol
- 928.27K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 30.98
- High
- 31.00
- Forward P/E
- 15.81
- Beta
- 1.74
- Short ratio
- 1.58
- Inst. own
- 102.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2024
- 50-d avg
- 30.73
- 200-d avg
- 22.52
- 1y target
- 30.50
3M chart
Events in this range
- Aug 7, 2024Earnings: —; estimate 0.49; surprise —%
- Aug 8, 2024Downgrade: Truist Securities · Buy → Hold
Signals (8)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Aug 27, 2024 | 2 years ago |
| SMA: Bullish | Aug 7, 2024 | 2 years ago |
| SMA: Bullish | Aug 7, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 7, 2024 | 2 years ago |
| RSI: Overbought | Aug 7, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 31, 2024 | 2 years ago |
| SMA: Bearish | Jul 30, 2024 | 2 years ago |
Key statistics
- Market cap
- 926.64M
- Enterprise value
- 1.30B
- Trailing P/E
- 83.73
- Forward P/E
- 15.81
- PEG ratio
- 0.68
- Price / sales
- 0.82
- Price / book
- 3.56
- EPS (TTM)
- 0.37
- Beta
- 1.74
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.16%
- Revenue (TTM)
- 1.13B
- Revenue growth
- 4.60%
- Free cash flow
- 2.18M
- Total cash
- 84.13M
- Total debt
- 460.59M
- Return on equity
- 5.52%
- Shares outstanding
- 29.67M
- Short % of float
- 3.72%
- 50-day average
- 30.73
- 200-day average
- 22.52
Analyst view
Consensus: buy
- Target (low)
- 30.00
- Target (mean)
- 30.50
- Target (high)
- 31.00
- Strong buy2
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2024
Expected Nov 5, 2024. Consensus EPS estimate 0.49.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2024 | Sep 1, 2024 | 0.36 | — | — | — |
| Aug 7, 2024 | Jun 1, 2024 | 0.49 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.42 | — | — | — |
| Feb 28, 2024 | Dec 1, 2023 | -0.29 | — | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.03 | — | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.26 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 8, 2024 | Truist Securities | down | Buy | Hold |
| May 10, 2024 | Benchmark | reit | Buy | Buy |
| Mar 19, 2024 | Jefferies | main | Buy | Buy |
| Dec 19, 2023 | Jefferies | init | — | Buy |
| Oct 2, 2023 | Truist Securities | main | Buy | Buy |
| Sep 6, 2023 | Lake Street | init | — | Buy |
About PetIQ, Inc.
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- petiq.com
News
- Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
- Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday
- Watching Shares Of Petco Health And Wellness Co, PetIQ, TDH Holdings, Wag! Group, Zomedica; Shares See A Spike In Volume To The Upside; Traders Speculate Roaring Kitty X Post Of A Picture Of A Dog Might Be A New Pet Play
- Earnings Scheduled For February 28, 2024
- Earnings Scheduled For November 7, 2023
- Earnings Scheduled For August 8, 2023
- Earnings Scheduled For May 9, 2023
- Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Earnings Scheduled For February 28, 2023
- Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Your note
Sign in to keep a note on PETQ — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CARTER WILLIAM JOHN | General Counsel | Conversion of Exercise of derivative security | Aug 27, 2024 | 3,497 |
| CHRISTENSEN MCCORD | Chief Executive Officer | Conversion of Exercise of derivative security | Oct 24, 2024 | 0 |
| FIRST MARK L | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 18,547 |
| HALL ALLAN | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 12,807 |
| HUFF SCOTT | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 18,194 |
| LEFKO KIMBERLY | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 14,822 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.14% | 3,009,661 | 93.24M | Jun 29, 2024 |
| Vanguard Group Inc | 7.39% | 2,191,956 | 67.91M | Jun 29, 2024 |
| Eos Management, L.P. | 6.65% | 1,972,687 | 61.11M | Jun 29, 2024 |
| Dimensional Fund Advisors LP | 4.17% | 1,236,632 | 38.31M | Jun 29, 2024 |
| Aristotle Capital Boston, LLC | 4.15% | 1,232,590 | 38.19M | Jun 29, 2024 |
| Boston Partners | 3.51% | 1,039,987 | 32.22M | Jun 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.78% | 826,067 | 25.59M | Jun 29, 2024 |
| iShares Russell 2000 ETF | 2.37% | 703,083 | 21.78M | Sep 29, 2024 |
| Thornburg Small/Mid Cap Core Fund | 2.15% | 637,975 | 19.76M | Jun 29, 2024 |
| Arbitrage Fund | 1.54% | 458,008 | 14.19M | Aug 30, 2024 |
| Vanguard Extended Market Index Fund | 1.38% | 408,882 | 12.67M | Jun 29, 2024 |
| Oberweis Micro-Cap Portfolio | 1.15% | 340,700 | 10.55M | Jun 29, 2024 |
